Gefitinib: a new agent in palliative care. [electronic resource]
- The American journal of hospice & palliative care
- 222-7 p. digital
Publication Type: Journal Article; Review
1049-9091
10.1177/104990910402100313 doi
Antineoplastic Agents--pharmacology Dose-Response Relationship, Drug Epidermal Growth Factor--antagonists & inhibitors Gefitinib Humans Lung Neoplasms--drug therapy Palliative Care--standards Protein-Tyrosine Kinases--antagonists & inhibitors Quinazolines--pharmacology Randomized Controlled Trials as Topic Treatment Outcome United States United States Food and Drug Administration